Pro PG receives S19 A for Imipramine 25mg Tablets - Extended until 31st August
- Jul 6, 2021
- 1 min read
Updated: Aug 28
Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position.
For current Australian shortage and supply information, see medicine shortages in Australia.
Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th June 2021.
Import and supply approved until: 31st August 2021 (now extended)
Imipramine 25mg tablets are currently experiencing a shortage of supply in Australia with Tofranil 25mg not available. This shortage is expected to continue until Mid 2021.
Product: IMIPRAMINE HYDROCHLORIDE TABLETS USP, 25 MG 100 TABLETS (LEADING PHARMA LLC) S19a
Stock availability: On hand
PBS Listing September 1st 2020 PBS Code: 12113M
Ordering
Orders can be placed via Wholesalers Symbion via the below PDE numbers.
PDE: 692379
Or via our website www.propg.com.au , email: orders@propg.com.au or phone: 1300 077 674
